Skip to content
Disclosery

Rhenman & Partners Asset Management AB

Follow

13F filer, CIK 1599882, Stockholm, Sweden

Rhenman & Partners Asset Management AB reported $810,489,964 across 86 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-05-14. Its ten largest share positions make up 32% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001213900-26-056196

Period
2026-03-31
Reported value
$810M
Holdings
86
Top 10 weight
32%
New
11
Sold out
19

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SYKnew+47,800$15.7M
VEEVnew+85,300$15M
BSXadded+193,793$12.2M
ABTnew+112,000$11.5M
WAYnew+342,566$8.26M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VERAexited-420,000-$21.3M
COOreduced-277,500-$19.8M
MDTreduced-206,000-$17.8M
ALGNreduced-91,500-$15.7M
DHRreduced-81,000-$15.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001213900-26-056196, largest first. % of portfolio is the value over $810,489,964, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 590,000 shares; 2024Q4: 444,000 shares; 2025Q1: 300,000 shares; 2025Q2: 296,000 shares; 2025Q3: 438,000 shares; 2025Q4: 431,207 shares; 2026Q1: 625,000 shares 625,000$39.2M4.84%+193,793Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 39,000 shares; 2024Q4: 43,457 shares; 2025Q1: 31,750 shares; 2025Q2: 27,700 shares; 2025Q3: 36,100 shares; 2025Q4: 61,400 shares; 2026Q1: 48,100 shares 48,100$37.2M4.59%-13,300Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 47,500 shares; 2024Q4: 45,450 shares; 2025Q1: 41,750 shares; 2025Q2: 57,870 shares; 2025Q3: 53,420 shares; 2025Q4: 42,220 shares; 2026Q1: 33,715 shares 33,715$31M3.83%-8,505Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 129,513 shares; 2024Q4: 61,500 shares; 2025Q1: 185,500 shares; 2025Q2: 175,435 shares; 2025Q3: 131,885 shares; 2025Q4: 113,585 shares; 2026Q1: 159,760 shares 159,760$26.1M3.22%+46,175Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 184,000 shares; 2024Q4: 267,500 shares; 2025Q1: 235,862 shares; 2025Q2: 295,362 shares; 2025Q3: 277,362 shares; 2025Q4: 335,500 shares; 2026Q1: 336,500 shares 336,500$24.2M2.98%+1,000Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 366,500 shares; 2024Q4: 255,500 shares; 2025Q1: 233,500 shares; 2025Q2: 168,150 shares; 2025Q3: 80,150 shares; 2025Q4: 126,150 shares; 2026Q1: 167,750 shares 167,750$23.4M2.88%+41,600Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 25,100 shares; 2024Q4: 15,640 shares; 2025Q1: 12,640 shares; 2025Q2: 11,140 shares; 2025Q3: 30,040 shares; 2025Q4: 33,640 shares; 2026Q1: 41,340 shares 41,340$20.3M2.51%+7,700Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 67,100 shares; 2024Q4: 123,700 shares; 2025Q1: 49,500 shares; 2025Q2: 12,000 shares; 2025Q3: 55,000 shares; 2025Q4: 92,350 shares; 2026Q1: 109,100 shares 109,100$20M2.47%+16,750Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 47,750 shares; 2024Q4: 50,000 shares; 2025Q1: 66,750 shares; 2025Q2: 61,455 shares; 2025Q3: 46,955 shares; 2025Q4: 34,255 shares; 2026Q1: 43,485 shares 43,485$19.4M2.4%+9,230Timeline
ALHCALIGNMENT HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,977,363 shares; 2024Q4: 1,761,192 shares; 2025Q1: 1,337,284 shares; 2025Q2: 1,287,284 shares; 2025Q3: 1,479,284 shares; 2025Q4: 1,009,450 shares; 2026Q1: 1,053,450 shares 1,053,450$18.6M2.29%+44,000Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 63,000 shares; 2024Q4: 64,000 shares; 2025Q1: 51,500 shares; 2025Q2: 44,350 shares; 2025Q3: 48,500 shares; 2025Q4: 48,000 shares; 2026Q1: 36,846 shares 36,846$17M2.1%-11,154Timeline
CORCENCORA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 45,150 shares; 2024Q4: 53,750 shares; 2025Q1: 32,375 shares; 2025Q2: 49,375 shares; 2025Q3: 62,375 shares; 2025Q4: 63,375 shares; 2026Q1: 52,375 shares 52,375$16.5M2.03%-11,000Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 23,000 shares; 2024Q4: 22,500 shares; 2025Q1: not reported; 2025Q2: 11,500 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 47,800 shares 47,800$15.7M1.94%newTimeline
ABBVABBVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 177,000 shares; 2024Q4: 124,150 shares; 2025Q1: 88,650 shares; 2025Q2: 69,375 shares; 2025Q3: 130,375 shares; 2025Q4: 110,575 shares; 2026Q1: 71,575 shares 71,575$15.6M1.92%-39,000Timeline
VEEVVEEVA SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 85,300 shares 85,300$15M1.85%newTimeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 30,117 shares; 2024Q4: 34,117 shares; 2025Q1: 47,217 shares; 2025Q2: 27,717 shares; 2025Q3: 26,600 shares; 2025Q4: 25,600 shares; 2026Q1: 16,850 shares 16,850$14.6M1.8%-8,750Timeline
JAZZJAZZ PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 93,000 shares; 2024Q4: 145,500 shares; 2025Q1: 124,300 shares; 2025Q2: 109,030 shares; 2025Q3: 95,030 shares; 2025Q4: 74,030 shares; 2026Q1: 75,890 shares 75,890$14.3M1.77%+1,860Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 80,000 shares; 2026Q1: 145,000 shares 145,000$13.4M1.65%+65,000Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 71,750 shares; 2024Q4: 100,317 shares; 2025Q1: 89,817 shares; 2025Q2: 149,217 shares; 2025Q3: 114,717 shares; 2025Q4: 125,491 shares; 2026Q1: 100,841 shares 100,841$13.3M1.64%-24,650Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 55,000 shares; 2025Q3: 155,000 shares; 2025Q4: 193,500 shares; 2026Q1: 163,000 shares 163,000$13.1M1.61%-30,500Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 15,300 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,250 shares; 2025Q4: 19,550 shares; 2026Q1: 24,050 shares 24,050$12.6M1.55%+4,500Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 72,700 shares; 2024Q4: 60,530 shares; 2025Q1: 77,430 shares; 2025Q2: 30,430 shares; 2025Q3: 62,530 shares; 2025Q4: 54,900 shares; 2026Q1: 45,500 shares 45,500$12.3M1.52%-9,400Timeline
PRCTPROCEPT BIOROBOTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 445,000 shares; 2024Q4: 420,345 shares; 2025Q1: 448,000 shares; 2025Q2: 190,000 shares; 2025Q3: 390,000 shares; 2025Q4: 611,000 shares; 2026Q1: 475,000 shares 475,000$11.9M1.47%-136,000Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 364,500 shares; 2024Q4: 250,623 shares; 2025Q1: 265,000 shares; 2025Q2: 149,650 shares; 2025Q3: 186,650 shares; 2025Q4: 215,000 shares; 2026Q1: 207,000 shares 207,000$11.7M1.44%-8,000Timeline
ABTABBOTT LABORATORIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 135,000 shares; 2024Q4: 128,000 shares; 2025Q1: 52,000 shares; 2025Q2: 58,500 shares; 2025Q3: 98,500 shares; 2025Q4: not reported; 2026Q1: 112,000 shares 112,000$11.5M1.42%newTimeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 50,350 shares; 2024Q4: 17,000 shares; 2025Q1: 48,197 shares; 2025Q2: 51,197 shares; 2025Q3: 31,875 shares; 2025Q4: 45,675 shares; 2026Q1: 34,465 shares 34,465$11.4M1.41%-11,210Timeline
RPRXROYALTY PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 613,500 shares; 2024Q4: 595,000 shares; 2025Q1: 411,000 shares; 2025Q2: 344,000 shares; 2025Q3: 258,500 shares; 2025Q4: 206,500 shares; 2026Q1: 233,000 shares 233,000$11.2M1.38%+26,500Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 122,600 shares; 2024Q4: 122,600 shares; 2025Q1: 109,600 shares; 2025Q2: 90,800 shares; 2025Q3: 172,800 shares; 2025Q4: 114,800 shares; 2026Q1: 63,800 shares 63,800$10.8M1.33%-51,000Timeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 231,000 shares; 2024Q4: 123,410 shares; 2025Q1: 138,500 shares; 2025Q2: 57,500 shares; 2025Q3: 31,000 shares; 2025Q4: 40,500 shares; 2026Q1: 51,600 shares 51,600$10.3M1.27%+11,100Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 221,400 shares; 2024Q4: 197,700 shares; 2025Q1: 126,700 shares; 2025Q2: 136,429 shares; 2025Q3: 58,429 shares; 2025Q4: 76,504 shares; 2026Q1: 54,000 shares 54,000$10.2M1.26%-22,504Timeline
ADPTADAPTIVE BIOTECHNOLOGIES CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 495,000 shares; 2025Q4: 605,000 shares; 2026Q1: 720,000 shares 720,000$9.99M1.23%+115,000Timeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 53,000 shares; 2025Q3: 53,000 shares; 2025Q4: 190,000 shares; 2026Q1: 155,000 shares 155,000$9.85M1.22%-35,000Timeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 50,500 shares; 2024Q4: 23,150 shares; 2025Q1: 48,950 shares; 2025Q2: 44,650 shares; 2025Q3: 22,500 shares; 2025Q4: 15,000 shares; 2026Q1: 32,300 shares 32,300$9.46M1.17%+17,300Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 144,500 shares; 2026Q1: 144,500 shares 144,500$9.06M1.12%0Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 111,000 shares; 2024Q4: 36,531 shares; 2025Q1: 270,000 shares; 2025Q2: 235,000 shares; 2025Q3: 230,000 shares; 2025Q4: 210,000 shares; 2026Q1: 84,000 shares 84,000$9.04M1.12%-126,000Timeline
IQVIQVIA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 48,000 shares; 2024Q4: 29,000 shares; 2025Q1: 22,000 shares; 2025Q2: 13,000 shares; 2025Q3: 19,500 shares; 2025Q4: 26,500 shares; 2026Q1: 53,000 shares 53,000$9.04M1.12%+26,500Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 259,500 shares; 2024Q4: 232,000 shares; 2025Q1: 433,000 shares; 2025Q2: 574,000 shares; 2025Q3: 574,000 shares; 2025Q4: 487,000 shares; 2026Q1: 379,250 shares 379,250$8.86M1.09%-107,750Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 105,000 shares; 2024Q4: 73,755 shares; 2025Q1: 73,755 shares; 2025Q2: 65,755 shares; 2025Q3: 56,255 shares; 2025Q4: 106,255 shares; 2026Q1: 92,605 shares 92,605$8.55M1.06%-13,650Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 127,500 shares; 2024Q4: 82,000 shares; 2025Q1: 39,500 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 250,000 shares; 2026Q1: 255,500 shares 255,500$8.51M1.05%+5,500Timeline
PNTGPENNANT GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 357,346 shares; 2026Q1: 275,399 shares 275,399$8.39M1.04%-81,947Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 90,000 shares; 2024Q4: 72,500 shares; 2025Q1: 52,500 shares; 2025Q2: 52,500 shares; 2025Q3: 52,500 shares; 2025Q4: 163,350 shares; 2026Q1: 81,200 shares 81,200$8.32M1.03%-82,150Timeline
WAYWAYSTAR HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 342,566 shares 342,566$8.26M1.02%newTimeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,290,000 shares; 2025Q2: 1,250,763 shares; 2025Q3: 1,250,763 shares; 2025Q4: 1,238,625 shares; 2026Q1: 1,438,625 shares 1,438,625$7.98M0.99%+200,000Timeline
MDTMEDTRONIC PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 368,000 shares; 2024Q4: 269,500 shares; 2025Q1: 255,000 shares; 2025Q2: 179,500 shares; 2025Q3: 205,000 shares; 2025Q4: 296,000 shares; 2026Q1: 90,000 shares 90,000$7.8M0.96%-206,000Timeline
OSCROSCAR HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,371,147 shares; 2024Q4: 1,362,421 shares; 2025Q1: 1,022,743 shares; 2025Q2: 312,092 shares; 2025Q3: not reported; 2025Q4: 260,000 shares; 2026Q1: 660,000 shares 660,000$7.57M0.93%+400,000Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,052,500 shares; 2024Q4: 1,235,448 shares; 2025Q1: 647,827 shares; 2025Q2: 647,827 shares; 2025Q3: 1,097,827 shares; 2025Q4: 1,595,327 shares; 2026Q1: 2,055,327 shares 2,055,327$7.21M0.89%+460,000Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 165,000 shares; 2025Q4: 142,571 shares; 2026Q1: 263,071 shares 263,071$7.13M0.88%+120,500Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 195,000 shares; 2024Q4: 212,500 shares; 2025Q1: 81,000 shares; 2025Q2: 182,000 shares; 2025Q3: 310,000 shares; 2025Q4: 158,500 shares; 2026Q1: 92,900 shares 92,900$6.98M0.86%-65,600Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 150,000 shares; 2024Q4: 114,000 shares; 2025Q1: 126,627 shares; 2025Q2: 126,627 shares; 2025Q3: 173,627 shares; 2025Q4: 98,627 shares; 2026Q1: 81,627 shares 81,627$6.85M0.85%-17,000Timeline
BBIOBRIDGEBIO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 268,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 81,600 shares; 2026Q1: 90,600 shares 90,600$6.73M0.83%+9,000Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 75,000 shares 75,000$6.31M0.78%newTimeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 70,000 shares; 2025Q2: 135,100 shares; 2025Q3: 180,100 shares; 2025Q4: 147,600 shares; 2026Q1: 128,100 shares 128,100$6.17M0.76%-19,500Timeline
CAHCARDINAL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 55,000 shares; 2025Q3: 94,000 shares; 2025Q4: not reported; 2026Q1: 27,000 shares 27,000$5.71M0.7%newTimeline
EHCENCOMPASS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 61,000 shares; 2024Q4: 56,000 shares; 2025Q1: 37,400 shares; 2025Q2: 136,400 shares; 2025Q3: 119,400 shares; 2025Q4: 146,263 shares; 2026Q1: 56,263 shares 56,263$5.44M0.67%-90,000Timeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,000 shares; 2024Q4: 3,000 shares; 2025Q1: 4,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 36,000 shares; 2026Q1: 15,200 shares 15,200$5.35M0.66%-20,800Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 102,500 shares; 2024Q4: 90,000 shares; 2025Q1: 100,000 shares; 2025Q2: 85,000 shares; 2025Q3: 216,288 shares; 2025Q4: 83,000 shares; 2026Q1: 160,000 shares 160,000$5.21M0.64%+77,000Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 300,000 shares; 2024Q4: 290,000 shares; 2025Q1: 249,336 shares; 2025Q2: 185,000 shares; 2025Q3: 347,500 shares; 2025Q4: 537,500 shares; 2026Q1: 313,500 shares 313,500$4.86M0.6%-224,000Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 133,000 shares; 2024Q4: 77,999 shares; 2025Q1: 39,000 shares; 2025Q2: 39,000 shares; 2025Q3: 94,000 shares; 2025Q4: 133,250 shares; 2026Q1: 133,250 shares 133,250$4.71M0.58%0Timeline
CRLCHARLES RIV LABS INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 37,500 shares; 2024Q4: 14,850 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 22,000 shares; 2026Q1: 26,000 shares 26,000$4.49M0.55%+4,000Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 45,000 shares; 2025Q2: 45,000 shares; 2025Q3: 207,000 shares; 2025Q4: 364,000 shares; 2026Q1: 239,500 shares 239,500$4.46M0.55%-124,500Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 17,000 shares; 2024Q4: 23,750 shares; 2025Q1: 17,750 shares; 2025Q2: 12,750 shares; 2025Q3: 11,750 shares; 2025Q4: 25,000 shares; 2026Q1: 16,675 shares 16,675$4.31M0.53%-8,325Timeline
DOCSDOXIMITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 21,000 shares; 2025Q3: 136,000 shares; 2025Q4: 372,750 shares; 2026Q1: 183,808 shares 183,808$4.28M0.53%-188,942Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 59,000 shares 59,000$4.25M0.52%newTimeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 100,000 shares; 2025Q2: 100,000 shares; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 199,000 shares 199,000$3.82M0.47%+99,000Timeline
STVNSTEVANATO GROUP S P AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 51,000 shares; 2025Q4: 147,025 shares; 2026Q1: 274,676 shares 274,676$3.78M0.47%+127,651Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 460,000 shares; 2024Q4: 460,000 shares; 2025Q1: 460,000 shares; 2025Q2: 460,000 shares; 2025Q3: 460,000 shares; 2025Q4: 460,000 shares; 2026Q1: 360,000 shares 360,000$3.58M0.44%-100,000Timeline
COOCOOPER COS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 228,000 shares; 2024Q4: 115,000 shares; 2025Q1: 236,000 shares; 2025Q2: 170,000 shares; 2025Q3: 237,000 shares; 2025Q4: 327,500 shares; 2026Q1: 50,000 shares 50,000$3.58M0.44%-277,500Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 87,500 shares 87,500$3.51M0.43%newTimeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 15,000 shares; 2026Q1: 15,000 shares 15,000$3.43M0.42%0Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 83,302 shares; 2024Q4: 63,952 shares; 2025Q1: 41,952 shares; 2025Q2: 121,452 shares; 2025Q3: 134,452 shares; 2025Q4: 99,052 shares; 2026Q1: 18,052 shares 18,052$3.42M0.42%-81,000Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 40,000 shares; 2024Q4: 57,000 shares; 2025Q1: 61,000 shares; 2025Q2: 46,000 shares; 2025Q3: 58,000 shares; 2025Q4: 61,000 shares; 2026Q1: 14,000 shares 14,000$2.94M0.36%-47,000Timeline
AAGILENT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 25,000 shares 25,000$2.85M0.35%+5,000Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 250,000 shares; 2025Q4: 216,000 shares; 2026Q1: 83,000 shares 83,000$2.7M0.33%-133,000Timeline
ESPRESPERION THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,975,000 shares; 2024Q4: 1,915,000 shares; 2025Q1: 1,066,495 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 985,000 shares 985,000$2.7M0.33%newTimeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 58,278 shares; 2024Q4: 58,278 shares; 2025Q1: 28,278 shares; 2025Q2: 28,278 shares; 2025Q3: 28,278 shares; 2025Q4: 153,278 shares; 2026Q1: 85,724 shares 85,724$2.58M0.32%-67,554Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 202,000 shares; 2025Q4: 265,000 shares; 2026Q1: 305,000 shares 305,000$2.58M0.32%+40,000Timeline
STESTERIS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 6,000 shares; 2026Q1: 11,500 shares 11,500$2.54M0.31%+5,500Timeline
VCELVERICEL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 58,000 shares; 2025Q3: 117,000 shares; 2025Q4: 117,000 shares; 2026Q1: 70,000 shares 70,000$2.25M0.28%-47,000Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 166,526 shares; 2024Q4: 314,526 shares; 2025Q1: 195,000 shares; 2025Q2: 250,000 shares; 2025Q3: 490,000 shares; 2025Q4: 872,000 shares; 2026Q1: 271,500 shares 271,500$2.21M0.27%-600,500Timeline
CITHE CIGNA GROUPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 41,685 shares; 2024Q4: 78,385 shares; 2025Q1: 28,200 shares; 2025Q2: 32,000 shares; 2025Q3: 46,500 shares; 2025Q4: 38,650 shares; 2026Q1: 8,000 shares 8,000$2.13M0.26%-30,650Timeline
BTSGBRIGHTSPRING HEALTH SVCS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,000 shares; 2025Q4: 198,000 shares; 2026Q1: 50,000 shares 50,000$2.13M0.26%-148,000Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 35,000 shares; 2024Q4: 35,000 shares; 2025Q1: 35,000 shares; 2025Q2: 35,000 shares; 2025Q3: 81,000 shares; 2025Q4: 139,000 shares; 2026Q1: 28,000 shares 28,000$1.63M0.2%-111,000Timeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 55,000 shares; 2024Q4: 41,900 shares; 2025Q1: 41,500 shares; 2025Q2: 66,500 shares; 2025Q3: 83,000 shares; 2025Q4: 99,000 shares; 2026Q1: 7,500 shares 7,500$1.29M0.16%-91,500Timeline
NVCRNOVOCURE LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 70,000 shares 70,000$763K0.09%newTimeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,000 shares; 2025Q4: 20,000 shares; 2026Q1: 70,000 shares 70,000$762K0.09%+50,000Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 115,113 shares 115,113$609K0.08%newTimeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VERAVERA THERAPEUTICS INC420,000$21.3Mshares
PENPENUMBRA INC31,500$9.79Mshares
APLSAPELLIS PHARMACEUTICALS INC374,450$9.41Mshares
ACLXARCELLX INC133,500$8.7Mshares
BRKRBRUKER CORP147,315$6.94Mshares
RYTMRHYTHM PHARMACEUTICALS INC35,000$3.75Mshares
RDNTRADNET INC47,000$3.35Mshares
INSPINSPIRE MED SYS INC35,800$3.3Mshares
JANXJANUX THERAPEUTICS INC225,377$3.11Mshares
PRVAPRIVIA HEALTH GROUP INC125,000$2.96Mshares
CYTKCYTOKINETICS INC44,375$2.82Mshares
XNCRXENCOR INC165,750$2.54Mshares
CNTACENTESSA PHARMACEUTICALS PLC100,000$2.5Mshares
TGTXTG THERAPEUTICS INC73,250$2.18Mshares
BNTXBIONTECH SE20,870$1.99Mshares
WSTWEST PHARMACEUTICAL SVSC INC7,000$1.93Mshares
CNCCENTENE CORP DEL46,231$1.9Mshares
QUREUNIQURE NV79,375$1.9Mshares
IRTCIRHYTHM HOLDINGS INC7,000$1.24Mshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001213900-26-056196 base2026-05-14acceptance time not in the bulk data set